GeneSys Biologics was founded with a mission to serve large diabetic patient population across the world with most affordable insulins. We specialize in making insulin biosimilars with a patient-first approach, taking a sincere shot at solving the world’s largest decades old problem. We aim to make an impactful difference in building healthy society.

We are a group of individuals driven by purpose who came together to make the inaccessible, accessible. Today, we have grown to 250+ personnel working hard on this noble mission of making affordable insulins a reality. We strive every day to create an impact on patients who are forced to ration the essential medicine. Our courage was fuelled by the diabetes patients, and we understand the diabetes disease and the burden it can have on families and communities at large. Our expertise lies in tailored-based CMC development that delivers the product with high similarity.